Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Androgen Receptor Antagonists × Clear all

NCT00103376 2018-11-05

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Phase 2 Terminated

23 enrolled 9 charts

Prostatic Neoplasms